Furthermore, a percentage of both TMEM119+ and P2RY12+ cells, markers that represent homeostatic microglia, expresses TSPO in MS lesions indicating that TSPO PET is not merely a reflection of pathogenic microglia, although the trigger of TSPO upregulation in MS CNS is still unclear. This evidence concerns the gene TSPO and myeloid sarcoma.